Compare GEOS & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEOS | NYXH |
|---|---|---|
| Founded | 1980 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.6M | 188.1M |
| IPO Year | 1997 | 2021 |
| Metric | GEOS | NYXH |
|---|---|---|
| Price | $15.18 | $4.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | ★ 302.0K | 41.8K |
| Earning Date | 02-04-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $110,803,000.00 | $6,616,215.00 |
| Revenue This Year | N/A | $79.25 |
| Revenue Next Year | N/A | $297.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.96 |
| 52 Week Low | $5.51 | $4.35 |
| 52 Week High | $29.89 | $11.87 |
| Indicator | GEOS | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 48.89 |
| Support Level | $14.17 | $4.69 |
| Resistance Level | $15.91 | $4.93 |
| Average True Range (ATR) | 1.29 | 0.18 |
| MACD | 0.40 | 0.02 |
| Stochastic Oscillator | 61.14 | 56.82 |
Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.